UMass Memorial Health
365 Plantation Street, Worcester, MA, 01605, United States
Overview
UMass Memorial Health Care (UMMHC) is the clinical partner of the University of Massachusetts Medical School and is the largest health care system in Central and Western Massachusetts.[1] UMMHC is a not-for-profit health care network providing all levels of primary to quartary health care.
- Total investments
- 2
- Lead investments
- 2
- Investments · 12mo
- 2
- Active investors
- 1
Sector focus
- Diabetes
- Education
- Health Care
- Hospital
- Medical
- Personal Health
Investment portfolio
- Wellinks
Led · Series B · Aug 2026
Wellinks delivers a predictive cardiopulmonary care solution that pairs virtual chronic disease management with its proprietary, FDA-cleared Spire Remote Patient Monitoring (RPM) system. Its Health Tags provide passive, continuous monitoring designed to identify physiologic changes and predict clinical deterioration up to one week before symptom onset. Wellinks and UMass Chan Medical School collaborated on the Healthy at Home program, which the company says showed participants had more than 60% lower odds of 30-day hospital readmission and trends toward fewer ED visits and shorter hospital stays. The company plans to use recent Series B proceeds to expand commercial reach, including into rural and underserved communities, and to apply its technology and care model to additional conditions such as congestive heart failure. Wellinks intends to leverage accumulating real-world clinical data to strengthen decision support and enhance its predictive capabilities. The company is headquartered in New Haven, Conn.
- Brook.ai
Led · Series B · Oct 2025
Brook.ai combines intelligent data collection, AI-driven insights, and remote clinical teams to extend care into patients’ homes without adding to clinician workloads. Its platform has demonstrated tangible clinical improvements, including a 90% reduction in congestive heart failure readmissions and an 80% rise in controlled hypertension populations within six weeks. High engagement underpins these outcomes, reflected in an 82% patient retention rate, a Net Promoter Score of 66, and 204% year-over-year patient growth. Brook’s personal health assistant—part AI, part nurse—has been trained on millions of patient conversations, delivering timely nudges and recommendations that bolster patient satisfaction and provider ROI. Revenue figures were not disclosed, but the company’s strong operating metrics and expanding customer base signal healthy traction. With fresh capital, Brook plans to enlarge its product and engineering teams (with an emphasis on safe AI), enhance product features to deepen engagement, broaden coverage to additional conditions, and scale operations nationwide. Ultimately, Brook.ai aims to make remote, proactive care a standard component of U.S. healthcare.
Team
Eric Dickson, MD
LinkedIn